Day One Biopharmaceuticals (DAWN) Insider Trading & Ownership $13.76 +0.13 (+0.95%) (As of 09/17/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Day One Biopharmaceuticals (NASDAQ:DAWN) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage8.40%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$3.87 MNumber OfInsiders Selling(Last 12 Months)5Amount OfInsider Selling(Last 12 Months)$5.06 M Get DAWN Insider Trade Alerts Want to know when executives and insiders are buying or selling Day One Biopharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address DAWN Insider Buying and Selling by Quarter Ad InvestorPlaceBig News: How the Upcoming Rate Cut and Elon Musk’s AI Could Transform Your InvestmentsThe Federal Reserve is almost certainly about to cut interest rates, and history tells us that stocks often rally after such moves. In fact, based on my calculations, in seven out of nine rate-cut cycles since 1981, stocks have surged, delivering an average of 36.3% returns over two years. But that's not all... This time, there's another massive trigger on the horizon – Elon Musk's groundbreaking AI technology.Click here to learn how you can take advantage of these two monumental shifts right now. Day One Biopharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails9/10/2024Samuel C BlackmanInsiderSell30,000$14.22$426,600.00 8/16/2024Adam DubowGeneral CounselSell3,202$14.00$44,828.00 8/16/2024Charles N York IICFOSell2,633$14.00$36,862.00 8/16/2024Jeremy BenderCEOSell10,681$14.00$149,534.00 8/16/2024Samuel C BlackmanInsiderSell2,232$14.00$31,248.00 7/16/2024Samuel C BlackmanInsiderSell20,000$16.01$320,200.00 Man who Predicted Trump 2016 Win: “Prepare for Election Meltdown” (Ad)Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… A predicted Trump would win. You won’t believe what he’s predicting now.Click here to see it because it’s a SHOCKER…6/21/2024Saira RamasastryDirectorSell10,000$13.19$131,900.00 5/16/2024Adam DubowGeneral CounselSell3,253$16.08$52,308.24 5/16/2024Charles N York IICFOSell2,675$16.08$43,014.00 5/16/2024Jeremy BenderCEOSell7,873$16.08$126,597.84 5/16/2024Samuel C BlackmanInsiderSell2,267$16.08$36,453.36 5/10/2024Samuel C BlackmanInsiderSell10,000$16.37$163,700.00 5/3/2024Charles N York IICFOSell8,078$17.85$144,192.30 5/3/2024Jeremy BenderCEOSell9,154$17.85$163,398.90 5/1/2024Charles N York IICFOSell52,183$17.89$933,553.87 5/1/2024Jeremy BenderCEOSell70,051$17.88$1,252,511.88 4/18/2024Samuel C BlackmanInsiderSell10,000$16.02$160,200.00 3/25/2024Samuel C BlackmanInsiderSell10,000$16.01$160,100.00 2/27/2024Samuel C BlackmanInsiderSell20,000$16.11$322,200.00 2/16/2024Adam DubowGeneral CounselSell3,242$15.25$49,440.50 2/16/2024Charles N York IICFOSell2,666$15.25$40,656.50 2/16/2024Jeremy BenderCEOSell7,615$15.25$116,128.75 2/16/2024Samuel C BlackmanInsiderSell2,258$15.25$34,434.50 11/16/2023Adam DubowGeneral CounselSell5,313$11.69$62,108.97 11/16/2023Charles N York IICFOSell956$11.69$11,175.64 11/16/2023Jeremy BenderCEOSell3,107$11.69$36,320.83 11/16/2023Samuel C BlackmanInsiderSell709$11.69$8,288.21 10/19/2023Ai Day1 LlcMajor ShareholderBuy384,400$10.06$3,867,064.00 (Data available from 1/1/2013 forward) DAWN Insider Trading Activity - Frequently Asked Questions Who is on Day One Biopharmaceuticals's Insider Roster? The list of insiders at Day One Biopharmaceuticals includes Adam Dubow, Ai Day1 Llc, Charles N York II, Jeremy Bender, Julie Papanek Grant, Michael Gladstone, Papanek Julie Grant, Pharmaceutical Co Ltd Takeda, Saira Ramasastry, Samuel C Blackman, and Xi L.P. Canaan. Learn more on insiders at DAWN. What percentage of Day One Biopharmaceuticals stock is owned by insiders? 8.40% of Day One Biopharmaceuticals stock is owned by insiders. Learn more on DAWN's insider holdings. Which Day One Biopharmaceuticals insiders have been buying company stock? The following insider purchased DAWN shares in the last 24 months: Ai Day1 Llc ($13,867,054.00). How much insider buying is happening at Day One Biopharmaceuticals? Insiders have purchased a total of 1,153,630 DAWN shares in the last 24 months for a total of $13,867,054.00 bought. Which Day One Biopharmaceuticals insiders have been selling company stock? The following insiders have sold DAWN shares in the last 24 months: Adam Dubow ($208,685.71), Charles N York II ($2,298,790.73), Jeremy Bender ($3,557,975.76), Julie Papanek Grant ($13,882,293.54), Saira Ramasastry ($131,900.00), Samuel C Blackman ($2,547,006.19), and Xi L.P. Canaan ($2,900,551.70). How much insider selling is happening at Day One Biopharmaceuticals? Insiders have sold a total of 1,376,016 Day One Biopharmaceuticals shares in the last 24 months for a total of $25,527,203.63 sold. More Insider Trading Tools from MarketBeat Related Companies: Arcutis Biotherapeutics Insider Buying MannKind Insider Buying Castle Biosciences Insider Buying LeMaitre Vascular Insider Buying Black Diamond Therapeutics Insider Buying Atai Life Sciences Insider Buying Sangamo Therapeutics Insider Buying Kinnate Biopharma Insider Buying Apellis Pharmaceuticals Insider Buying Avidity Biosciences Insider Buying Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: Matador Resources Insiders Keep Buying Its Stock, Should You?Top 3 Small-Cap Stocks Insiders Are Buying Right Now3 Small Cap Stocks That Insiders Are BuyingMGM Insiders Bet Big on Its Undervalued Stock3 Small Cap Stocks Insiders Are Actively Buying This page (NASDAQ:DAWN) was last updated on 9/17/2024 by MarketBeat.com Staff From Our PartnersSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | SponsoredI’m giving you the name of this investment for freeNow that the Federal Reserve lowered interest rates, this investment could easily go up 50%.Porter & Company | SponsoredChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | SponsoredJeff Bezos Just Humiliated Elon MuskThe Next Nvidia? Wall Street legend has just uncovered one tiny Maryland company that could become the next...InvestorPlace | SponsoredYour Crypto Future is at StakeWhat if I told you that bananas could make you a millionaire? No, this isn't a joke – I'm talking about the...Crypto 101 Media | SponsoredKamala Harris and The Woke Progressive NightmareNew research from Jim Rickards - former advisor to the CIA - reveals shocking predictions about an “Election M...Paradigm Press | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist My Default Watchlist Adding Day One Biopharmaceuticals, Inc. You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Please log in to your account or sign up in order to add this asset to your watchlist. Share Day One Biopharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
